Name (Synonyms) | Correlation | |
---|---|---|
drug2499 | Therapeutic anticoagulation Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D054556 | Venous Thromboembolism NIH | 0.38 |
D020141 | Hemostatic Disorders NIH | 0.30 |
D001778 | Blood Coagulation Disorders NIH | 0.30 |
D013923 | Thromboembolism NIH | 0.27 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001928 | Abnormality of coagulation HPO | 0.30 |
HP:0001907 | Thromboembolism HPO | 0.24 |
There is one clinical trial.
The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.
Description: Presence of IgG and/or IgM antibodies
Measure: IgG/IgM antibodies Time: from date of consent to date of test completion, up to 40 days